European Journal of Chemistry

Anticancer activity studies of some cyclic benzimidazole derivatives

Article Sidebar

PDF
Published: Sep 30, 2012
DOI: https://doi.org/10.5155/eurjchem.3.3.356-358.621
Keywords:
PC3 cells, Hela cells, Cytotoxicity, Anti-cancer activity, Benzimidazole derivatives, 4-Amino-2-(3, 4, 5-trimethoxyphenyl)benzo[4, 5]imidazo[1, 2-a]pyrimidine-3-carbonitrile
Section
Research Article
Issue
Vol. 3 No. 3 (2012): September 2012
Dates
Received 2012-04-23
Accepted 2012-06-17
Published 2012-09-30


Main Article Content

Ali El-Shekeil
Chemistry Department, Faculty of Science, Sana’a University, 2463, Sana’a, Yemen
Abeer Omer Obeid
Chemistry Department, Faculty of Science, Sana’a University, 2463, Sana’a, Yemen
Sama Al-Aghbari
Chemistry Department, Faculty of Science, Sana’a University, 2463, Sana’a, Yemen

Abstract

New benzimidazole derivatives, namely, (N-(4-methoxyphenyl)methylene]-1H-benzimidazol-2-amine (2a), (N-(3,4-dimethoxyphenyl)methylene]-1H-benzimidazol-2-amine (2b), and (N-(3,4,5-trimethoxyphenyl)methylene]-1H-benzimidazol-2-amine (2c) were synthesized by reaction of a Schiff base with malononitrile in absolute ethanol. Structures of compounds have been confirmed by IR, 1H NMR and elemental analysis. Compounds 2a-c were screened for their in vitro anticancer potential using HeLa and PC3 cells. All compounds showed limited cytotoxicity except compound 2a that showed a moderate cytotoxic effect towards HeLa cells.

3_3_356_358_800


icon graph This Abstract was viewed 3153 times | icon graph Article PDF downloaded 1152 times

How to Cite
(1)
El-Shekeil, A.; Obeid, A. O.; Al-Aghbari, S. Anticancer Activity Studies of Some Cyclic Benzimidazole Derivatives. Eur. J. Chem. 2012, 3, 356-358.

Article Details

Share
Links for Article


Crossref - Scopus - Google - European PMC
Crossref
Scopus
Google Scholar
Europe PMC
References

[1]. Ramla, M. M.; Omer, M. A.; El-Khamry, A. M. M.; El-Diwani, H. I. Bioorg. Med. Chem. 2006, 14, 7324-7332.
http://dx.doi.org/10.1016/j.bmc.2006.06.033

[2]. Yang, Y. H.; Cheng, M. S.; Wang, Q. H.; Nie, H.; Liao, N.; Wang, J.; Chen, H.; Design. Eur. J. Med. Chem. 2009, 44, 1808-1812.
http://dx.doi.org/10.1016/j.ejmech.2008.07.021
PMid:18762358

[3]. Penning, T. D.; Zhu, G. D.; Gandhi, V. B.; Gong Thomas, S. J.; Lubisch, W.; Gradel, R.; Wernet, W.; Park, C. H.; Fry, E. H.; Liu X.; Shi, Y.; Klinghofer, V.; Johnson, E. F.; Donawho, C. K.; Frost, D. J.; Diaz, V. B.; Bouska, J. J.; Olson, A. M.; Marsh, K. C. Bioorg. Med. Chem. 2008, 16, 6965-6975.
http://dx.doi.org/10.1016/j.bmc.2008.05.044

[4]. Garuti, L.; Roberti, M.; Pizzirani, D.; Pession A.; Leoncini, E.; Cenci, V.; Hrelia, S. Il Farmaco 2004, 59, 663-668.
http://dx.doi.org/10.1016/j.farmac.2004.04.001
PMid:15262537

[5]. Spasov, A. R.; Iezhitsa, I. N.; Bugaeva, L. I.; Anisimova, V. A. Khim. Farm. Zh. 1999, 33, 6-12.

[6]. Parshanth, A.; David, W. W. J. Am. Chem. Soc. 2009, 131, 7618-7624.
http://dx.doi.org/10.1021/ja809249h
PMid:19445463 PMCid:2698132

[7]. Klimesova, V.; Koci, J.; Pour, M.; Stachel, J.; Waisser, K.; Kaustova, J. Eur. J. Med. Chem. 2002, 37, 409-420.
http://dx.doi.org/10.1016/S0223-5234(02)01342-9

[8]. Sondhi, S. M.; Singhal, N.; Johar, M.; Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 2002, 9, 1045-1074.
http://dx.doi.org/10.2174/0929867024606678
PMid:12733983

[9]. Demirayak, S.; Mohsen, U. A.; Karaburun, A. C. Eur. J. Med. Chem. 2002, 37, 225-260.
http://dx.doi.org/10.1016/S0223-5234(01)01313-7

[10]. Huang, S. T.; Hsei, I. J.; Chen, C. Bioorg. Med. Chem. 2006, 14, 6106-6119.
http://dx.doi.org/10.1016/j.bmc.2006.05.007

[11]. Boiani, M.; Gonzalez, M. Mini-Rev. Med. Chem. 2005, 5, 409-424.
http://dx.doi.org/10.2174/1389557053544047
PMid:15853629

[12]. Hori, A.; Imaeda, Y.; Kubo, K.; Kusaka, M. Cancer lett. 2002, 183, 53-62.
http://dx.doi.org/10.1016/S0304-3835(02)00110-6

[13]. Nawrocka, W; Sztuba, B.; Kowalska, M. W.; Liszkiewicz, H.; Wietrzyk, J.; Nasulewicz, A.; Pelczynska, M.; Opolski, A. Il Farmaco 2004, 59(2), 83-91.
http://dx.doi.org/10.1016/j.farmac.2003.12.001
PMid:14871499

[14]. Mosmann, T. J. Immunol. Methods 1983, 65(1-2), 55-63.

Supporting Agencies

Sana’a University, Sana’a, Yemen
Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2025 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).